Clinical Trials Logo

Methamphetamine Abuse clinical trials

View clinical trials related to Methamphetamine Abuse.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06233799 Not yet recruiting - Clinical trials for Methamphetamine Abuse

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

Start date: May 1, 2024
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.

NCT ID: NCT05971043 Not yet recruiting - Clinical trials for Methamphetamine Abuse

Skin Disease in Methamphetamine Abuse

Start date: August 3, 2023
Phase:
Study type: Observational

1. To detect the skin diseases in patients using methamphetamine

NCT ID: NCT05784467 Not yet recruiting - Hiv Clinical Trials

Methamphetamine, PrEP, and Intersectional Stigma Study

eMPrISe
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trail is to test the developed eMPrISe study in HIV-negative, adult, Latino men who have sex with men (MSM) who use non-injection substances. The main questions it aims to answer are: - Can participation in the developed eMPrISe study reduce methamphetamine ('meth') use risk? - Can participation in the developed eMPrISe study improve preexposure prophylaxis (PrEP) cascade progression? Participants will participate in 12 weekly modules that: (1) build critical thinking skills, (2) identify and discuss the link between oppression and harmful behaviors, (3) take action, (4) voice and validate feelings and experiences, and (5) share knowledge and resources.

NCT ID: NCT05593796 Not yet recruiting - Clinical trials for Methamphetamine Abuse

Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The efficacy of cognitive behavioral therapy(CBT) in treatment of methamphetamine use disorder

NCT ID: NCT05334914 Not yet recruiting - Clinical trials for Methamphetamine Abuse

ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

This study aims to assess the feasibility, acceptability and preliminary effectiveness of Acceptance Commitment Therapy, in conjunction with motivation enhancement, and the use of the ChillTime App, in reducing methamphetamine use in women with MUD with or without co-occurring psychiatric disorders. This intervention is designed to be delivered remotely (e.g., participants can complete the entire study from home), with the option for in person attendance if it is not feasible or safe for participants to attend from home.

NCT ID: NCT01273701 Not yet recruiting - Clinical trials for Methamphetamine Dependence

Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence

Start date: January 2011
Phase: N/A
Study type: Interventional

The hospital where this study will be conducted is responsible for the one-year contingency management treatment for methamphetamine drug offenders referred from the Yunlin District Prosecutors Office. Completing the one-year treatment is prerequisite for offenders to get slow prosecutions. It is an open-label, parallel-group trial comparing the combination of psychosocial intervention and slow prosecutions with psychosocial intervention alone in treating subjects with methamphetamine dependence Study Hypothesis 1. Psychosocial interventions in combination with slow prosecutions is more effective than psychosocial interventions alone to achieve abstinence for subjects with methamphetamine abuse/dependance. 2. Inclusion of telephone reminding before each visit will enhance the retention rate and abstinence rate.